Among patients with advanced #BiliaryTractCancer, durvalumab plus gemcitabine and cisplatin provided sustained 4-year overall survival benefit and a comparable safety profile vs placebo plus chemotherapy ja.ma/4ygxazN

The draft guideline recommendations for "Integration of Patient-Reported Outcomes in the Routine Care of Adults Undergoing Systemic Treatment for Cancer" are now available. Help us refine these standards of care. Submit your feedback to us by July 22: https://bit.ly/4h3Xkzx

🚨 @ascocancer.bsky.social #ASCOQLTY26 provides an unparalleled opportunity to present data-driven science to help educate the oncology community & elevate care for all. It's the LAST DAY to share your work & contribute to the conversation on patient-centered outcomes. 👉 www.asco.org/quality

Propel your career forward by submitting your research on topics ranging from Cost, Value & Policy to Tech. Innovation in Quality Care to #ASCOQLTY26 in Boston. Let’s advance quality cancer care together. ☕ Grab your Dunks & submit an abstract by June 16 at 11:59 PM (ET): https://bit.ly/49NsXsK

Among patients with early age–onset #ColorectalCancer in Texas, treatment delays longer than six weeks were associated with reduced survival, and language barriers represented a major risk factor contributing to delayed initiation of definitive therapy. ja.ma/3S1igN7

Older adults with advanced cancer mainly prioritized quality of life, but their treatment preferences were not associated with differences in survival, hospitalization, or adverse effects. ja.ma/3RwiJH5

Heading home from #ASCO26 today! Put two dates for @ascocancer.bsky.social Quality Care Symposium on your calendar: 🚨Abstracts are due in 2 weeks 6/16/2026 📆 #ASCOQLTY26 is Friday-Saturday 10/16-17/2026 See you in Boston! www.asco.org/quality

Adding intraperitoneal paclitaxel to intravenous paclitaxel plus S-1 improved overall survival for #GastricCancer with peritoneal metastasis, with safety profiles comparable to intravenous-only therapy. ja.ma/3PA3fAX

Rural counties had stable or increased #LiverCancer (#HCC) incidence and mortality rates from 2001 to 2022, while urban counties experienced decreases, highlighting persistent rural-urban disparities. ja.ma/4nvw0ve

Cancer cachexia: A tumor-driven disorder of whole-body homeostasis

Recommend a colleague by June 5, 2026, for the upcoming ASCO Election. Learn more and submit your recommendations: https://bit.ly/4cKmkYI

Elevate the quality, safety & efficiency of cancer care delivery—submit your research to #ASCOQLTY26. By presenting findings, you’re shaping a vibrant community of professionals dedicated to advancing patient care. Prepare your submission: https://bit.ly/4cF0WUW

Older adults with advanced #cancer mainly prioritized quality of life, but their treatment preferences were not associated with differences in survival, hospitalization, or adverse effects. ja.ma/4bf65m0

Dr @lpetrillz.bsky.social accepts the #EarlyCareer Investigator award here at @aahpm.bsky.social's #hapc26 for her innovative and revolutionary work in #pallonc and #survonc. Well deserved!! 👏 @realbowtiedoc.bsky.social @darcyburbage.bsky.social @ascocancer.bsky.social @crisbergerot.bsky.social

Outcomes of Older Adults With Advanced #Cancer Who Prefer Quality of Life vs Prolonging Survival: A Secondary Analysis of the GAP70+ Cluster Randomized Clinical Trial. jamanetwork.com/journals/jam... @jama.com @jamaoncology.com #GeriOnc #SuppOnc @mycarg.bsky.social

Analysis of US mortality data indicates breast cancer, lung cancer, and leukemia deaths decreased in people younger than 50, while #ColorectalCancer mortality rose to become the leading cancer death by 2023. ja.ma/4qN1RII

Among #Medicare Advantage beneficiaries aged 75 years or older with #cancer, a lay health worker–administered telephone assessment reduced acute care use, including 68% lower odds of hospitalization, compared with standard care. ja.ma/4plhA05

💬 Editorial: A randomized trial in community oncology clinics demonstrated that telephone-based lay health worker–administered PRO assessments for older adults with #cancer resulted in reductions in acute care utilization and lower mortality. ja.ma/4ax5ygt

Among over 7000 patients with #cancer, higher baseline fatigue before systemic therapy was linked to an increased risk of severe, life-threatening, and fatal adverse events. ja.ma/4qmZtrt

Great session! Thank you @ryannipp.bsky.social ! Mark your calendars for #ASCOQuality in Boston on 10/16-10/17/2026!

Join us this Thursday to hear the highlights from #ASCOQLTY25 with #ASCOQLTY Chair Elect @ryannipp.bsky.social DM for the link or to be added to our mailing list. @realbowtiedoc.bsky.social @crisbergerot.bsky.social @ericroeland.bsky.social @fionnualacrowley.bsky.social #pallonc

💕 A big “thank you” to our #ASCOQLTY25 Featured Voices! Their expertise and insights are invaluable. We're so lucky to have them! @fumikochino.bsky.social @crisbergerot.bsky.social @ryannipp.bsky.social

Great to hear an expert discussion on #FinancialToxicity from Dr. Jeffrey Peppercorn at #ASCOQLTY25 this afternoon! meetings.asco.org/2025-asco-qu... @ascocancer.bsky.social #PallOnc #SuppOnc #CancerResearch

I am honored to give the #ASCOQLTY25 Simone Award to @drrobinyabroff.bsky.social today. Dr Yabroff has a profound impact as a researcher, policy advocate, & mentor. It's hard to find someone in health services research that hasn't been positively influenced by her intellect, wit, & warmth.🏆

Excellent first session this morning at #ASCO Quality Care Symposium: “Partners in Care: Building Bridges Through Shared Decisions.” meetings.asco.org/meetings/202... #ASCOQLTY25 #CancerCare #CancerResearch @ascocancer.bsky.social

The 2025 @ascocancer.bsky.social Quality Care Symposium #ASCOQLTY25 will feature >600 abstract presentations covering the latest implementation science and the entire spectrum of health services research. 📖 Review abstracts today! ✈️ Join us this weekend in Chicago meetings.asco.org/abstracts-pr...

🚨 #ASCOQLTY25 Registration Alert‼️ (before rates go up this Friday)! 🗣️ Engage in meaningful discussions 🤝 Build lasting relationships 🔋 Leave feeling energized & inspired ➡️ Join us in Chicago Oct 10-11, 2025 @ascocancer.bsky.social www.asco.org/quality/registration-hotels/registration-details

Chair-Elect @ryannipp.bsky.social, MPH, FASCO, attended @ascocancer.bsky.social Quality as a trainee, and the science, education, and community he found there has kept him coming back.   “For many of us, it is our favorite meeting of the year." #ascoQLTY25

Truly honored to be a featured voice at #ASCOQLTY25 alongside such inspiring colleagues who are shaping the future of quality cancer care Join us in Chicago & online, Oct 10–11, for sessions on shared decision-making, advancing quality cancer care and much more @ascocancer.bsky.social

We’re excited to announce the ASCO Quality Care Symposium Featured Voices! Follow them before, during & after the event for expert insights & to be a part of the meeting experience. Join the conversation w/ the official hashtag #ASCOQLTY25. Registration is still open: brnw.ch/21wVoQS

Despite high insurance coverage rates, individuals diagnosed with #cancer in Massachusetts experienced increases in medical debt, with those having bladder and colorectal cancer facing additional increases. ja.ma/4p1IivY

Our study tested GAIN-S in older adults w metastatic cancer 🇧🇷 ➡️ GAIN-S improved emotional + adaptive aspects of prognostic awareness vs usual care Full paper acsjournals.onlinelibrary.wiley.com/doi/10.1002/... Thanks to #WilliamDale #EnriqueSoto @paulobergerot.bsky.social @ryannipp.bsky.social

⏰Discounted access to the 2025 @ascocancer.bsky.social Quality Care Symposium is ending soon! Join us at #ASCOQLTY25 the premier meeting addressing quality, safety, & efficiency of cancer care delivery. 📆 Early Registration by: Wed, September 3 at 11:59 PM (ET)

Clinical trial-related financial considerations from Deep South-patients with breast #cancer who previously declined trial participation. link.springer.com/article/10.1... @cancercaremascc.bsky.social #FinancialToxicity #BreastCancer #CancerResearch @grocquemd.bsky.social @cphilwil.bsky.social

Gather with peers and friends who share your dedication to addressing quality, safety, and efficiency in #CancerCare delivery and join us in Chicago, October 10-11, for #ASCOQLTY25. Early registration closes on Sept. 3. Reserve your space today: brnw.ch/21wUEIk

While phase 3 oncology trials frequently report success based on alternative endpoints, actual enhancements in overall survival and quality of life are uncommon. ja.ma/4f5YdVl

📢 Just published in JNCCN ! Our RCT shows that a telehealth GA & #SuppCare Intervention (GAIN-S) improved physical function, mood & QoL in older Brazilians with metastatic cancer @ryannipp.bsky.social jnccn.org/view/journal...

Malnutrition in Older Adults. www.nejm.org/doi/full/10.... @nejm.org #Geriatrics #GeriOnc #PallOnc

🚨 @oncoalert.bsky.social Deadline Alert TODAY‼️ #ASCOQLTY25 Abstracts are due tonight! Engage in meaningful discussions, build lasting relationships, & leave feeling energized & inspired; join us in Chicago Oct 10-11, 2025. 👉 asco.org/quality @ascocancer.bsky.social

🚨Deadline Alert TOMORROW‼️ 📅 Tuesday, June 10 #ASCOQLTY25 @ascocancer.bsky.social Abstract submissions are due this week! Share your solutions-driven research & help shape the future of quality cancer care. Don’t miss the premier forum for innovation in care delivery! 👉 asco.org/quality

This #ASCOEdBook paper discusses the advances in targeted therapies & immunotherapies to treat #PancreaticCancer & cautions that clinical trials should answer questions that matter to patients. Learn more: brnw.ch/21wTgZn

Connect with us near the Chicago lakefront this autumn to delve into the latest, data-driven, interdisciplinary cancer science aimed at improving the lives of people living with cancer everywhere. Register today for #ASCOQLTY25: brnw.ch/21wTdvO

Always grateful for the #gerionc community that we have and it feels like we have all grown up #fasco #asco25 @mycarg.bsky.social @wilmotcancer.bsky.social @msedrak.bsky.social @ryannipp.bsky.social

Amazing being introduced as #FASCO with my incredible @ascocancer.bsky.social Leadership Development Program friends at #ASCO25. 🙌 Drs Mina Sedrak and @ryannipp.bsky.social

BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation. ascopubs.org/doi/full/10.... @ascocancer.bsky.social #ASCO25 #PallOnc #CancerResearch

‼️ #ASCO25 simultaneous publication by Jacobs et al:  BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation. Read the full article: ascopubs.org/doi/10.1200/...

Cancer Surveillance in the United States in Jeopardy: Leveraging 21st Century Technology to Enhance Public Health. ascopubs.org/doi/full/10.... @ascocancer.bsky.social @americancancersoc.bsky.social #CancerResearch #CancerCare #Healthcare #MedTech @drrobinyabroff.bsky.social

The most clinically relevant science in oncology will be presented at #ASCO25, and you can now view the full 5,000 abstracts & their presentation date, time & location info: brnw.ch/21wSRrH

Time to Treatment Initiation for the 30 Most Prevalent #Cancer Types: Trends and Predictors of Change. ascopubs.org/doi/10.1200/... @ascocancer.bsky.social #CancerTreatment #CancerResearch #CancerCare

Oncology, Primary Care, and Survivorship: Time for Onco-primary Care? ascopubs.org/doi/10.1200/... @ascocancer.bsky.social #Survivorship #PallOnc #CancerCare @dcrinews.bsky.social @dukemedschool.bsky.social @dukecancer.bsky.social